Perlman syndrome (Q63594): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:05, 14 August 2026
Perlman syndrome is characterised principally by polyhydramnios, neonatal macrosomia, bilateral renal tumours (hamartomas with or without nephroblastomatosis), hypertrophy of the islets of Langerhans and facial dysmorphism.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_795682441 |
||
| English | Perlman syndrome |
Perlman syndrome is characterised principally by polyhydramnios, neonatal macrosomia, bilateral renal tumours (hamartomas with or without nephroblastomatosis), hypertrophy of the islets of Langerhans and facial dysmorphism. |
Statements
CID11:ID_795682441
0 references
dki-india-ID_795682441
0 references
Concluído
0 references
13 August 2026
0 references
